News · Longevity & Aging
Metformin added nothing to exercise in older adults
A randomized trial in The Lancet Healthy Longevity gave 114 older adults with obesity an intensive lifestyle program, with metformin or a dummy pill. The drug added no extra improvement in physical function.
Based on a randomized, placebo-controlled trial in 114 older adults with obesity
- 114 adults with obesity, average age 73, randomized across three arms for six months.
- Lifestyle plus metformin beat diet education plus metformin by 2.5 points (95% CI, 1.2 to 3.8).
- Lifestyle plus metformin versus lifestyle plus placebo: 0.1 points (95% CI, -1.2 to 1.4).
- So the exercise and weight-management program did the work; the drug added nothing.
- 89% of participants were men, which is the main limit on reading this across.
Metformin has spent a decade being described as a possible anti-aging drug. A trial in The Lancet Healthy Longevity gave it to older adults already doing the hard version of the alternative, and found it added nothing.
The setup is worth stating carefully, because the result depends on it.
The question
Obesity in older adults is associated with functional decline and increased risk of disability, and exercise programs are known to help. What is not known is whether a drug can add to that.
So the researchers evaluated whether metformin enhances the effects of an intensive lifestyle intervention on physical function in older adults with obesity. Not whether metformin works on its own. Whether it works on top.
How it was built
Participants were randomly assigned to intensive lifestyle intervention (weight-management and exercise training) plus placebo, intensive lifestyle intervention plus metformin, or healthy lifestyle (diet education) plus metformin groups.
Prior research had tested metformin against usual care, which cannot separate the drug from the effort. Three arms rather than two is the design decision that makes this one readable. One pair isolates the drug: both arms did the intensive program, and only one got metformin. The other pair isolates the program: both arms took metformin, and only one did the intensive version.
The primary outcome was change in the modified physical performance test score at 6 months, a scored set of everyday tasks such as walking, stairs and rising from a chair.
Of those screened, 114 were included in this study, with a mean age of 72.8 years.
What they found
The program worked. Physical performance test improvement was greater in the intensive lifestyle plus metformin group than in the healthy lifestyle plus metformin group, by 2.5 points.
The drug did not. There was no difference between the intensive lifestyle plus metformin and intensive lifestyle plus placebo groups, where the gap was 0.1 points and the range around it ran in both directions.
Read those two sentences together and the trial has answered its question cleanly. Everyone in the comparison was taking metformin or not against the same background, and the improvement tracked the program every time.
Safety was unremarkable: serious adverse events were infrequent and not attributed to the study interventions.
What this does not settle
Eighty-nine percent of the participants were men. For a study of older adults, in a field where women carry more of the disability burden, that is a real limit rather than a footnote, and the trial cannot speak to whether the same is true in women.
The trial is also six months long and 114 people. A null result in a small trial is weaker evidence of absence than the same result in a large one, and this one was built to detect a difference in a scored test rather than in falls, independence or survival.
And metformin is not being asked here to do its actual job. This says nothing about the drug for blood sugar, which is what most people taking it are taking it for.
Why it matters anyway
The anti-aging framing around metformin has run ahead of the evidence for years, and trials like this are how that gets corrected: not with a dramatic harm, but with a careful comparison in which the drug simply does not add anything.
The trial’s own reading is that metformin does not provide additional improvement in physical function in older adults already doing the work.
Which leaves the work. The program moved a measure of whether someone can climb stairs and get out of a chair, and it did that whether or not a pill came with it.
People also ask
What is metformin doing in a study about physical function?
Metformin is a cheap diabetes drug that has been studied for years as a possible anti-aging agent, on the theory that it mimics some effects of calorie restriction. Trials have tested it against everything from cancer to frailty. This one asked a narrower question: in older adults already doing an intensive exercise and weight-loss program, does adding metformin improve physical function further? The answer was no.
What does the physical performance test actually measure?
It is a scored set of everyday tasks, things like walking, climbing stairs, rising from a chair and lifting an object, combined into a single number. It is used because it tracks the abilities that decide whether someone stays independent, rather than something abstract like grip strength alone. The trial's primary outcome was the change in that score at six months.
So does the trial say metformin is useless?
Not in general, and not for its actual job of managing blood sugar. It says that for this outcome, in this group, on top of an intensive lifestyle program, it added nothing measurable. That is a narrower claim, and it is the one the trial was built to answer. Its own conclusion is that metformin does not provide additional improvement in physical function in that setting.
Was the lifestyle program itself worth doing?
Yes, and that is the useful half of the result. The group doing intensive lifestyle plus metformin improved 2.5 points more than the group doing diet education plus metformin (95% CI, 1.2 to 3.8). Everyone in both of those groups took the drug, so the difference between them is what the exercise and weight-management program bought.
How much should a 73-year-old read into this?
This is general information, not personal medical advice, and anyone on metformin should not change how they take it based on a news article. The transferable point is that the effort went into the program rather than the pill. Anyone with a medical condition should get individual guidance before starting an exercise program.